From: Type 2 diabetes and obesity induce similar transcriptional reprogramming in human myocytes
 | Control | OB | T2D | T2D&OB | P value |
---|---|---|---|---|---|
Sex | 3Â M/3Â F | 3Â M/3Â F | 3Â M/3Â F | 3Â M/3Â F | - |
Age, years | 48–63 | 41–56 | 50–63 | 46–63 | 0.155 |
BMI, kg/m2 | 24.0 ± 0.6b,d | 35.2 ± 3.6a,c | 24.4 ± 2.7b,d | 33.2 ± 2.8a,c | 2.04e-07 |
Fasting glucose (0 h), mmol/l | 5.4 ± 0.6c | 5.7 ± 0.5 | 9.0 ± 3.8a | 8.1 ± 1.4 | 0.0156 |
Glucose (2 h), mmol/l | 5.2 ± 1.0c,d | 5.5 ± 1.2c,d | 18.0 ± 7.3a,b | 16.4 ± 3.5a,b | 1.12e-05 |
Insulin (0 h), pmol/l | 25 ± 7d | 60 ± 33 | 38 ± 35 | 79 ± 43a | 0.0438 |
Insulin (2 h), pmol/l | 175 ± 123 | 197 ± 153 | 281 ± 303 | 509 ± 376 | 0.137 |
HOMA-IR | 0.47 ± 0.13d | 1.13 ± 0.61 | 0.81 ± 0.72 | 1.61 ± 0.83a | 0.0347 |
Cholesterol (total), mmol/l | 5.2 ± 0.8 | 4.9 ± 0.3 | 5.1 ± 0.7 | 5.0 ± 0.6 | 0.918 |
Cholesterol (HDL), mmol/l | 1.7 ± 0.5 | 1.3 ± 0.3 | 1.4 ± 0.4 | 1.2 ± 0.3 | 0.202 |
Cholesterol (LDL), mmol/l | 2.8 ± 0.5d | 3.4 ± 0.6 | 3.1 ± 0.4 | 3.6 ± 0.5a | 0.0512 |
Triglycerides, mmol/l | 1.0 ± 0.2 | 1.2 ± 0.8 | 1.7 ± 0.8 | 2.1 ± 0.7 | 0.0586 |
Free fatty acids (0 h), mmol/l | 0.31 ± 0.09c,d | 0.44 ± 0.13 | 0.56 ± 0.22a | 0.61 ± 0.07a | 0.0078 |
Free fatty acids (2 h), mmol/l | 0.07 ± 0.03 | 0.07 ± 0.04 | 0.13 ± 0.05 | 0.13 ± 0.03 | 0.0182 |